John Northcott
Corporate Officer/Principal bei ARVINAS, INC.
Profil
John Northcott is currently the Chief Commercial Officer at Arvinas, Inc. Prior to this, he was the Chief Commercial Officer & Senior Vice President at Nektar Therapeutics from 2019 to 2022, the Chief Commercial Officer at Pharmacyclics LLC from 2015 to 2019, and the VP-Marketing, Commercial Strategy & Operations at Lexicon Pharmaceuticals, Inc. from 2013 to 2015.
Mr. Northcott received his undergraduate degree from St. Francis Xavier University.
Aktive Positionen von John Northcott
| Unternehmen | Position | Beginn |
|---|---|---|
| ARVINAS, INC. | Corporate Officer/Principal | 01.08.2022 |
Ehemalige bekannte Positionen von John Northcott
| Unternehmen | Position | Ende |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 30.06.2022 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01.01.2019 |
| LEXICON PHARMACEUTICALS, INC. | Chief Operating Officer | 01.12.2015 |
Ausbildung von John Northcott
| St. Francis Xavier University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| ARVINAS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
